MBF Therapeutics
PrivateLast Round
Angel
Oct 12, 2022
Total Funding Raised
$3.6M
Company Overview
MBF Therapeutics operates in Healthcare & Life Sciences and is based in Warminster, England. Its latest recorded funding round was an Angel round in October 2022.
MBF Therapeutics is a biotechnology company that develops a DNA vaccine platform designed to create products for infectious diseases and cancer in the animal health markets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MBF Therapeutics Comparables
Compare MBF Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Torigen Pharmaceuticals, Inc. | 76% | |
| Vetigenics Inc. | 74% | |
| Mazen Animal Health | 74% |
For institutional investors. Book with your work email.
MBF Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Oct 12, 2022 | ||||
| VC Round | May 16, 2018 | ||||
| Seed | Jan 31, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MBF Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | VC Round, Angel, Seed |
| Keiretsu Forum Mid-Atlantic | Series S-2 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 99% MoM, reaching 2.4K.
- Feb 25, 2025
Monthly visitors grew 60% MoM.
For institutional investors. Book with your work email.
MBF Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MBF Therapeutics's valuation, stock price, and market status.
Is MBF Therapeutics a public or private company?
MBF Therapeutics is a private company.
What is the current stock price of MBF Therapeutics?
MBF Therapeutics is a private company, so its shares have no public market price. Caplight tracks MBF Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MBF Therapeutics worth (valuation)?
Valuation information for MBF Therapeutics is not publicly available.
Can I buy MBF Therapeutics stock?
MBF Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MBF Therapeutics's last funding round?
MBF Therapeutics's most recent funding round was Angel on October 12, 2022.
Who are the main investors in MBF Therapeutics?
Key investors in MBF Therapeutics include Benjamin Franklin Technology Partners, Keiretsu Forum Mid-Atlantic.
Will MBF Therapeutics IPO soon?
No public IPO plans have been announced for MBF Therapeutics.
How can I track MBF Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in MBF Therapeutics's shares on secondary markets.